TC
About
Thynk Capital possess a historical investment performance in the top 1% of venture capital. Focused on investments in early stage pharma and biotech companies focused on extending HealthSpan and major diseases of Aging including Alzheimer's, Dementia, Kidney Disease, Cancer, Cardiovascular, Diabetes, Frailty, and Rare Disease which affect over 25% of the population and growing at 10%/year.
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 275 investors are based in Las Vegas, Nevada, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech biotech
- Location
- Las Vegas, US
Contact Information
linkedin.com/in/••••••••
Find more investors like Thynk
Search Investors